Achieving the best outcome in treatment of depression

Journal of Family Practice, March, 2003 by John E. Sutherland, Steven J. Sutherland, James D. Hoehns

* For a review of screening for depression, see Nease DE, Malouin JM. Depression screening: A practical strategy. J Fam Pract 2003; 52(2):118-126.

REFERENCES

(1.) Whooley MA, Simon GE. Managing depression in medical outpatients. N Engl J Med 2000; 343:1942-1950.

(2.) Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system for psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000; 342:1462-1470.

(3.) Cohen L. Rational drug use in the treatment of depression. Pharmacotherapy 1997; 17:45-61.

(4.) Bhatia SC, Bhatia SK. Depression in women: diagnostic and treatment considerations. Am Fam Physician 1999; 60:225-240.

(5.) Glass RM. Treating depression as a recurrent or chronic disease. JAMA 1999; 281:83.

(6.) Harwitz. D, Ravizza L. Psychiatric emergencies; suicide and depression. Emergency Medical Clinics of North America 2000; 18:263-271.

(7.) Olfson M, Marcus S, Druss B, et al. National trends in the outpatient treatment of depression. JAMA 2002: 287:203-209.

(8.) Stahl SM. Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects. J Clin Psychiatry 1998; 59(suppl 18):23-29.

(9.) Stahl SM. Depression and bipolar disorders. In: Stahl SM. Essential Psychopharmacology, Neuroscientific Basis and Clinical Applications. Cambridge: Cambridge University Press, 1996;135-295.

(10.) Barbui C, Hotopf M, Freemantle N, et al. Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs) (Cochrane Review). In: The Cochrane Library, 1, 2002. Oxford; Update Software.

(11.) Geddes JR, Freemantle N, Mason J, et al. Selective serotonin reuptake inhibitors (SSRIs) for depression (Cochrane Review). In: The Cochrane Library, 1, 2002. Oxford: Update Software.

(12.) Banerjee S, Shamash K, Macdonald AJD, Mann AH. Randomized controlled trial of effect of intervention by psychogeriatric team on depression in frail elderly people at home. BMJ 1996; 313:1058-1061.

(13.) Reynolds III CF, Frank E, Perel JM, et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. JAMA 1999; 281:39-45.

(14.) Katon W, Von Korff M, Lin E, et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry 1999; 56:1109-1115.

(15.) Fava GA, Rafanelli C, Grandi S, Grandi S, Conti S, Belluardo P. Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. Arch Gen Psychiatry 1998; 55:816-820.

(16.) Linde K, Mulrow CD. St John's wort for depression (Cochrane Review). In: The Cochrane Library, 1, 2002. Oxford; Update Software.

(17.) Williams Jr JW, Mulrow CD, Chiquette E, et al. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med 2000; 132:743-756.

(18.) Lecrubier Y, Clerc G, Didi R, Kleser M. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Am J Psychiatry 2002; 159:1361-1366.